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The purpose of this study was to generate human embryonic stem cell (hESC) lines 
harbouring the green fluorescent protein (GFP) reporter at the endogenous loci of the Cone-
Rod Homeobox (CRX) gene, a key transcription factor in retinal development. ZFNs designed 
to cleave in the 3’ UTR of CRX were transfected into hESCs along with a donor construct 
containing homology to the target region, eGFP reporter and a puromycin selection cassette. 
Following selection, PCR and sequencing analysis of antibiotic resistant clones indicated 
targeted integration of the reporter cassette at the 3’ of the CRX gene, generating a CRX-
GFP fusion. Further analysis of a clone exhibiting homozygote integration of the GFP 
reporter was conducted suggesting genomic stability was preserved and no other copies of 
the targeting cassette were inserted elsewhere within the genome. This clone was selected 
for differentiation towards the retinal lineage. Immunocytochemistry of sections obtained 
from embryoid bodies and quantitative RT-PCR of GFP positive and negative subpopulations 
purified by fluorescence activated cell sorting during the differentiation indicated a 
significant correlation between GFP and endogenous CRX expression. Furthermore, GFP 
expression was found in photoreceptor precursors emerging during hESC differentiation, 
but not in the retinal pigmented epithelium (RPE), retinal ganglion cells or neurons of the 
developing inner nuclear layer. Together our data demonstrate the successful application of 
ZFN technology to generate CRX-GFP labelled hESC lines, which can be used to study and 







Page 2 of 44
































































Zinc finger nucleases (ZFNs) are designer nucleases which can be engineered to 
target a specific DNA sequence, offering huge potential for genetically modifying cells with 
complex genomes, such as mammalian cells [1]. ZFNs are comprised of a DNA binding 
domain of zinc finger protein motifs (N terminal) fused to the FokI endonuclease domain (C 
terminal), a DNA cleaving domain which operates upon dimerisation [1]. ZFNs are thus 
designed to work as a pair; upon binding to target sites on opposing strands, they act as a 
heterodimer and cleave both strands of the DNA. Once the ZFN pair creates a DNA double 
strand break (DSB) the cell´s inherent DNA repair process is stimulated. In the absence of a 
repair template, up to 20% of cells can be inaccurately repaired via non homologous end 
joining (NHEJ), resulting in the imprecise deletion or insertion of bases. In the presence of a 
donor template containing regions of homology to the target region, homologous 
recombination can occur resulting in the faithful copying of a template into the endogenous 
loci, enabling the incorporation of exogenous sequences inserted between two “arms” or 
regions of homology. Whilst only transient expression of ZFNs is required over a brief period 
of in vitro culture, the resulting genetic manipulation is present for the life of the cell, 
avoiding the need for continued expression of a foreign transgene. The potential for gene 
targeting and editing in various complex genomes is therefore considerable and has been 
realised in multiple organisms [1]. 
One important application is genetic modification of human pluripotent stem cells. 
Gene targeting of mouse embryonic stem cells using classical homologous recombination-
based methods has been widely used, however such conventional gene targeting 
approaches are not easily transferred to human embryonic stem cells (hESCs), mainly due to 
a substantial reduction in efficiency (~10
-6
, and [2]). However, seminal reports have shown 
that ZFN technology can be used to carry out precise genome modification of hESCs and 
human induced pluripotent stem (hiPSC) cells with greater efficiency [3,4]. One application 
of ZFN technology is to aid the insertion of reporter genes into a specific loci of a genome, 
rather than relying on the transfection of promoter-driven reporter genes, which often 
integrate at undetermined sites in the genome that are subject to silencing [5]. By 
integrating into the endogenous loci the reporter gene is under the same transcriptional 
control as the gene itself and thus can give a more accurate representation of a genes 
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activity, as well as protein localisation in the case of reporter fusions. In hESCs, reporters 
have been used to assess the activity of pluripotency or differentiation markers, as the 
modification created in the hESCs will be present in the differentiating cells arising from 
these stem cells. Because the reporter gene should be expressed at a distinct differentiation 
stage, it should then be possible to use FACS to capture and purify stage-specific cells during 
tissue morphogenesis. The captured cells can then be characterized in order to define 
potential stage-specific markers, thus enabling basic biological studies of differentiation and 
the isolation of progenitor cells derived from human pluripotent stem cells that has not 
previously been possible. This ability is of particular importance for the isolation of hESC- 
and hiPSC-derived retinal progenitor cells for which unique cell surface markers are lacking, 
and for which there is a pressing demand for basic biological studies and cell replacement 
applications [6]. 
To date, reporter-based studies for the selection of retinal progenitor cells have 
been very successful in the mouse [7,8] and this work has shown that the ontogenetic stage 
of the donor cell is a critical factor for its integration into an adult retina. These studies have 
highlighted that cells which express Nrl (neural retina leucine zipper gene) during early 
postnatal development display a rod phenotype upon transplantation, while those isolated 
during the embryonic peak of cone genesis and which express Crx (cone-rod homeobox 
gene),  display a cone phenotype following transplantation with a shift towards the rod 
phenotype if isolated from postnatal retina [7,8]. hESC and hiPSC differentiation towards 
retinal lineages has undergone substantial advances with the advent of 3D strategies [9-12]; 
however the same momentum has not been reached with regard to the successful 
integration of hESC- and hiPSC-derived retinal progenitors transplanted into the adult retina. 
This could in part be due to the lack of available cell surface markers that can be used to 
purify desired cell types prior to transplantation, an incomplete understanding of the 
optimal ontogenetic stage at which to capture differentiating hESCs and hiPSCs to facilitate 
their functional integration following transplantation, or the inability of current in vitro 
culture conditions to generate progenitor cells that are developmentally equivalent to the 
Nrl- and Crx-expressing cells isolated from postnatal murine retina.  To begin to answer 
some of these questions, we set out to generate hESC lines that harbour reporter genes 
under the control of key transcription factors known to play an important role in retinal 
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photoreceptor cell commitment. We chose CRX as a candidate for the following reasons: (i) 
CRX expression is localized to post-mitotic photoreceptor precursors prior to the 
development of outer segments [13]; (ii) clear evidence from animal studies that CRX plays 
an essential role in cone and rod genesis [14]; and (iii) existing evidence that the gene’s cis 
regulatory regions can direct reporter gene expression in photoreceptor cells in transgenic 
studies [15]. Our studies reported herein show that ZFNs can accurately target the CRX gene 
and enable the introduction of a GFP reporter at the 3’ terminus of this gene. Furthermore, 
expression of the GFP reporter mimics the expression of endogenous CRX during the 
differentiation of hESCs towards a retinal lineage, enabling the fluorescent labelling of CRX-
expressing cells with GFP during the differentiation process. Immunocytochemistry with 
various retinal markers up to day 90 of hESC differentiation indicates that CRX expression is 
observed in hESC-derived photoreceptor precursors which have exited the cell cycle and 
lack the expression of well-established markers characterising the early eye field, retinal 
ganglion cells and the inner nuclear layer. Together, these data suggest that CRX-GFP 
labelled hESC lines created using ZFNs provide an excellent tool with which to study retinal 
development in vitro and photoreceptor precursors at various stages of differentiation, 
which can be utilised to help define the integration potential of hESC-derived photoreceptor 
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Materials and Methods 
hESC culture and differentiation 
The H9 hESC line from WiCell Inc. was used in this study. Expansion of hESCs was 
performed on feeder cells as previously described [16]. The differentiation of H9 CRX-GFP 
reporter lines towards retinal lineages was performed at least three times under three 
dimensional (3D) culture conditions, using bacteriological Petri dishes (BD Biosciences) and 
IGF-1 supplemented media as described in our recent publication [12].  
 
Preparation of ZFN pair, donor construct and nucleofection 
The ZFN pair used was designed, produced and activity tested in K562 cells by Sigma-
Aldrich (Suppl. Table 1 and Suppl. Figure 1A). The activity in hESCs was tested following 
nucleofection of the ZFN pair mRNA (Suppl. Figure 1B). H9 cells were dissociated with 
Accutase (Life Technologies); 8x105 cells then underwent nucleofection with 2µg of each 
ZFN mRNA using the Human Stem Cell Nucleofector Kit 1 (Lonza) with a Nuclefector 2b 
device (Lonza). Following nucleofection cells were cultured as before, with the addition of Y-
27632 for 24 hours, and genomic DNA extracted (Quick-gDNA MiniPrep, Zymo Research) 48 
hours later. The frequency of cleavage products was then assessed using the SURVEYOR 
(CEL-I) Mutation Detection Kit (Transgenomic), following the manufacturer’s instructions) 
Suppl. Figure 1B). Briefly, PCR of the region harbouring the target site of the ZFN pair was 
performed from the genomic DNA (for primers see Suppl. Table 1), the PCR products were 
denatured and then cooled to anneal oligonucleotides, followed by incubation with the CEL-
I enzyme at 42⁰C for 40 minutes. The digests were then run on a 10% PAGE-TBE gel and the 
fraction of cleaved products assessed.  
The design of the donor construct was based on a published sequence by 
Hockemeyer et al. [3], previously used for insertion of a GFP reporter, and included 5’ and 3’ 
CRX homology arms, eGFP and a PGK-Puro-pA selection cassette (Figure 1A, and full 
sequence in Suppl. Figure 2). The construct was synthesised [and cloned into pBS II SK(+)] by 
Eurofins Genomics. The donor DNA was prepared for transfection by using the QIAGEN 
Plasmid Plus Maxi kit, followed by linearisation with PscI and gel purification (QIAquick Gel 
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Extraction Kit, QIAGEN). Nucleofections were performed as before with 2.5µg donor DNA 
and 2µg of each ZFN mRNA for 8x105 H9 cells. 48 hours post-nucleofection the media was 
supplemented with 0.5ug/ml Puromycin for 48 hours. Emergent colonies were isolated and 
expanded.   
 
Pluripotency assays 
The expression of pluripotency markers in H9 hESCs harbouring CRX-GFP was 
determined using the PSC Immunocytochemistry Kit (Life Technologies), following 
manufacturer’s guidelines. Briefly, colonies were fixed in 4% paraformaldehyde, 
permeabilised with 1% Saponin, blocked with 3% bovine serum albumin (BSA), incubated 
with OCT4 and SSEA4 antibodies (see Suppl. Table 3 for details) for 3 hours, washed in PBS, 
incubated with appropriate secondary antibodies for 1 hour, washed, incubated with DAPI 
and imaged on a Nikon A1R confocal microscope. At least 10 colonies from each clone were 
assessed for pluripotency. 
Pluripotency of the H9 CRX-GFP clones was then tested by spontaneous 
differentiation and assessment of the expression of germ layer markers identifying 
ectoderm (TUJ1), endoderm (AFP) and mesoderm (SMA). Colonies were dissociated by 
collagenase IV (Life Technologies) and allowed to form embryoid bodies (EBs) in suspension 
in low-attachment plates containing a general differentiation medium (KO-DMEM, 20% 
foetal bovine serum, GlutaMAX, 1% NEAA & 1% Pen-Strep). Medium was changed daily for 7 
days, EBs were then transferred onto gelatin-coated chamber slides and cultured for a 
further 7 days. Presence for markers of the germ layers were then assessed using the 3-
Germ Layer Immunocytochemistry Kit (Life Technologies) following manufacturers 
guidelines. Briefly, colonies were fixed in 4% paraformaldehyde, permeabilised with 1% 
Saponin, blocked with 3% BSA, incubated with TUJ1, AFP and SMA antibodies (see Suppl. 
Table 3 for details) for 3 hours, washed in PBS, incubated with appropriate secondary 
antibodies for 1 hour, washed, incubated with DAPI and imaged on a Nikon A1R confocal 
microscope. At least five EBs from each clone were assessed for markers of the three germ 
layers.  
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PCR, sequencing and copy number analysis 
To detect the presence or absence of correctly targeted insertion of the GFP reporter 
cassette, PCR was performed using GoTaq Long PCR Master Mix (Promega), primers flanking 
the 5’ and 3’ CRX homology arm sequences (see Suppl. Table 1) and genomic DNA extracted 
(Quick-gDNA MiniPrep, Zymo Research) from puromycin-resistant colonies. PCR products 
were resolved on a 1% agarose-TAE gel.Sequencing was performed by Eurofins Genomics on 
genomic DNA extracted from puromycin-resistant colonies and using primers flanking and 
residing across the donor construct (for primer details see Suppl. Table 1). 
Copy number analysis of GFP puromycin-resistant clone 1 genomic DNA was carried 
out using a qPCR approach with TaqMan Copy Number Assays and Genotyping Master Mix 
(Life Technologies) following manufacturers guidelines. Briefly, a duplex qPCR reaction was 
performed with an RNase P reference and GFP assay (see Suppl. Table 1 for details) to 
quantify the copy number of GFP using clone 1 genomic DNA alongside untreated wild-type 
H9 hESC genomic DNA. 4 technical replicates were performed for each sample. Reactions 
were run on a 7500 Fast Real-Time PCR System (Life Technologies) and data analysed in 
Copy Caller software (Life Technologies). 
 
Investigation of off-site ZFN cleavage 
For the prediction of potential off-target binding sites for the 3’ CRX ZFN pair the 
PROGNOS online tool [17] was used. PCR using the primers designed with this tool was then 
performed (for primer details see Suppl. Table 2). PCR products were sequenced by Eurofins 
Genomics (for sequences see Suppl. Table 2). Sequences were subject to BLAST analysis to 
confirm the presence of insertions or deletions around the predicted off-target site.  
 
Immunocytochemistry 
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EBs resulting from the directed differentiation of hESCs towards a retinal phenotype 
were collected at days 30, 60 and 90 of differentiation and immunocytochemistry analysis 
performed on cryostat sections as previously described [16]. A panel of retinal antibodies 
listed in Suppl. Table 3 were used for this analysis. At least five EBs from each differentiation 
were sampled for immunofluorescent histochemistry. Images were obtained using a Zeiss 
Axio Imager.Z1 microscope with ApoTome.2 accessory equipment and AxioVision software. 
 
Flow activated cell sorting and quantitative RT-PCR 
EBs were disassociated into single cells using 0.05% Trypsin for 30 minutes. Trypsin 
was inactivated with serum-containing media and the cells washed with PBS. Cells were 
sorted on a FACS Aria (BD) into GFP positive and negative fractions. RNA was extracted from 
each fraction (Quick-RNA MicroPrep, Zymo Research), cDNA synthesised (High Capacity 
cDNA Reverse Transcription Kit, Life Technologies), preamplified (TaqMan PreAmp Master 
Mix, Life Technologies) and qPCR performed (TaqMan Gene Expression Master Mix, Life 
Technologies) using a QuantStudio7 system and software (Life Technologies). For TaqMan 
assays used see Suppl. Table 1. Statistical analysis was performed using GraphPad Prism 
software (Version 6.05) with statistical significance tested using Student’s t-test. 
 
Karyotype analysis 
Karyotypes were determined by standard G-banding procedure as described 





 hESC were injected subcutaneously into the right flank of in adult SCID 
mice and maintained for 8-12 weeks [18]. All cells were co-transplanted with 50µl Matrigel 
(BD Biosciences) to enhance teratoma formation.  Two to three animals were injected for 
each clone.  After 8-12 weeks mice were sacrificed, tissues were dissected, fixed in Bouins 
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overnight, processed and sectioned according to standard procedures and counterstained 
with either haematoxylin and eosin or Massons Trichrome stain.  Sections (5-8µm) were 
examined using bright field light microscopy and photographed as appropriate. 
 
Results 
1. Generation and characterisation of CRX-GFP targeted hESC clones 
We chose to introduce the GFP reporter at the 3’ end of the CRX gene in order to avoid 
disruption of the coding sequence, preventing the loss of CRX function and maximising the 
maintenance of protein localisation and function. For this reason we mutated the stop 
codon of CRX introduced in the targeting cassette, which was followed by the eGFP 
sequence (Figure 1A and Suppl. Figure 2), thus resulting in a CRX-GFP fusion upon ZFN pair 
cutting in the 3’UTR of CRX and insertion of the targeting cassette via homologous 
recombination.  
Eighty two colonies arose from the initial puromycin-treated culture following 
nucleofection. Of these, 24 were picked and expanded. Three of these clones were 
characterised for the correct integration of the targeting cassette. PCR across the 
integration site using primers positioned in the genomic DNA and flanking the 5’ and 3’ CRX 
homologous arms of the donor cassette was performed. This analysis indicated that one of 
the three selected clones, ‘clone 1’, harboured a homozygous integration and the other two 
harboured heterozygous integrations (Figure 1B). Sequencing across the integration site was 
also performed, including the CRX-eGFP fusion border and the homology arm-endogenous 
genome border confirming correct targeted integration at the 3’ end of the CRX gene in 
each clone (Figure 1A). All three clones were characterised for karyotypic stability (Suppl. 
Figure 3A) and maintenance of a pluripotent phenotype using in vitro assays both at the 
proliferative stage (Suppl. Figure 3B) and following differentiation towards all three germ 
layers (Suppl. Figure 3C), in addition to in vivo teratoma formation assays (Suppl. Figure 3D). 
As we set out to assess whether ZFN technology could be used to precisely tag a gene of 
interest with minimal disruption of the gene environment in order to produce an accurate 
reporter of gene expression then the most stringent test for this was to use a clone where 
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homozygous tagging of the gene had occurred and for this reason we continued our 
analyses with clone 1. Further analysis to assess the genomic fidelity of clone 1 following 
ZFN-mediated tagging was then conducted. Quantitative PCR based copy number analysis of 
GFP revealed the presence of two copies of GFP (Figure 1C), corroborating the PCR and 
sequencing data and suggesting that no additional copies of GFP were present in the 
genome due to non-targeted insertion of the donor cassette. In addition, the 15 most likely 
genomic sites for targeting by the ZFN pair were predicted (Suppl. Table 2) using the 
PROGNOS online tool [17]. Using the primers generated from this analysis genomic DNA 
from clone 1 was amplified and sequenced. This analysis indicated no insertions, deletions 
or integration at predicted off-target sites.  Together our data suggest that ZFN targeting at 
the 3’ end of CRX in hESCs does not affect the maintenance of genomic stability or 
pluripotency.  
 
2. GFP reporter mimics the expression of endogenous CRX during retinal 
differentiation of hESC targeted clones 
The CRX-GFP targeted hESC clones were subjected to our 3D differentiation protocol 
described in Ref. [12]. This protocol utilises a single growth factor (IGF-1) and results in 
formation of laminated neural retina comprising a range of well differentiated retinal 
phenotypes [12]. This differentiation method relies on the mechanical transfer of hESC 
colonies to suspension conditions, forming 3D EBs which give rise to laminated neural 
retinal tissue displaying apically positioned photoreceptors; however a minority of EBs show 
internal cellular rosettes exhibiting a central hollow lumen with CRX positive cells found 
towards the internal surface. In accordance with this, we were able to detect GFP positive 
cells residing in the apical aspect of developing retinal tissue (Figure 2A-D) as well as the 
internal aspect of retinal rosettes (Figure 2E-L) during the 90 day differentiation protocol.  
On days 30, 60 and 90 of differentiation, floating EBs were collected and subjected to 
immunocytochemical analysis using antibodies directed against GFP and CRX (Figure 2A-L). 
This analysis showed an identical correlation between GFP and endogenous CRX expression 
throughout the time-course of differentiation. Furthermore, the detection of GFP 
expression could be carried out without the need for an anti-GFP antibody (Figure 2M). 
Together our data suggest that a GFP reporter introduced at the 3’ terminal of CRX does not 
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adversely affect the expression of CRX and can accurately mimic the expression of 
endogenous CRX.  
 
3. CRX/GFP expression is confined to photoreceptor precursors during hESC 
differentiation 
Throughout the differentiation period immunocytochemical analysis was performed 
using markers characterising the early stages of eye field formation, emergence of 
photoreceptor precursors, mature photoreceptors and other retinal phenotypes. Co-
immunostaining with an anti-GFP antibody at day 60 of differentiation revealed no co-
expression with early eye field markers (Suppl. Figure 4), indicating that CRX is not 
expressed with RAX6 or PAX6 during the early stages of optic cup formation. As 
differentiation proceeded, abundant RECOVERIN expression was observed at days 60 and 90 
(Figure 3A, 3B and 4A) in the outer nuclear layer of the developing optic cup as reported in 
our recent publication [12]. Interestingly, all RECOVERIN-positive cells co-expressed CRX, 
while only 70% of CRX-expressing cells were double-labelled with RECOVERIN (data not 
shown). A similar expression pattern was observed in the developing human retina at 16 
and 18 weeks of gestation (Suppl. Figure 5A-D). Furthermore, there was no overlap in the 
expression of GFP with Ki67, suggesting that the CRX-expressing cells were non-proliferative 
(Figure 3G and 4F). In addition, no CRX expression was observed in the emerging RPE layer 
(data not shown) over the differentiation period.  
Expression of cone photoreceptor markers (OPN1SW and OPN1MW+OPN1LW) was 
tested at days 60 and 90 of differentiation and a punctate cytoplasmic expression pattern 
was observed (Figures 3C-D and Figures 4B-C), perhaps indicative of very early stages of 
cone photoreceptor genesis which lacks the typical plasma membrane localisation of Opsins 
reported at later stages of differentiation [11]. Similar findings were reported by Kaewkhaw 
et al. [19] who noted minimal short wave opsin and no rhodopsin or medium and long wave 
opsin expression at day 90 of hESC differentiation. Double-labelling of tissue with GFP and 
cone photoreceptor markers (Opsin Blue/OPN1SW and Opsin 
Red+Green/OPN1MW+OPN1LW, Figures 3C-D and Figures 4B, C) or Calbindin (expressed in 
several cell types including cone photoreceptors, Figure 3E) indicated no obvious co-
expression, suggesting a lack of CRX expression in developing cone photoreceptors 
emerging within hESC derived optic cups on days 60 and 90 of hESC differentiation.  
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No co-expression was observed for CRX with PKCα (expressed in Rod ON Bipolar 
Cells, Figure 4D) or HuC/D (expressed in amacrine and ganglion cells, Figure 3F and 4E) or, 
suggesting a lack of CRX expression in retinal ganglion cells and developing inner nuclear 
layer retinal neurones. These results were further corroborated by fluorescence-activated 
cell sorting combined with quantitative RT-PCR (Figures 4G-I) where significantly higher 
expression of retinal photoreceptor precursor markers (CRX, RECOVERIN and CONE 
ARRESTIN) was found in the GFP positive fraction (Figure 4H). In contrast, higher expression 
of markers of post mitotic rod precursors (NRL) (Figure 4H), mature rods (RHO) and cone 
photoreceptors (OPN1SW, OPN1MW, OPN1LW) were found in the GFP negative fraction 
(Figure 4I). To evaluate the developmental stage of CRX-GFP positive cells, we performed 
qRT-PCR analysis of the same markers in the developing human retina obtained at 18 weeks 
of gestation. CRX was expressed at similar levels, whilst RECOVERIN was expressed at a 
higher level in the developing retina when compared to the CRX-GFP positive population 
(Figure 4H). Conversely, cone arrestin was expressed at higher levels in the CRX-GFP positive 
population (Figure 4H). Together these data suggest that the CRX-GFP positive population 
shows similarities to the 18 week foetal retina with high expression of photoreceptor 
markers but due to the greater cone expression may be at a different developmental stage 
or consist of an enriched precursor population, however to fully ascertain this further 
investigation with expression studies at other developmental and differentiation time points 
would be required and are beyond the scope of this paper. 
In summary, our data suggest that CRX expression is confined to two cell types 
during the first 90 days of hESC differentiation, namely RECOVERIN-expressing 
photoreceptor precursors situated in the developing outer nuclear layer of the optic cup 
and in a subpopulation of retinal progenitors that appear to be non-proliferative but do not 
yet express any of the markers characterising the mature retinal phenotypes that we have 
tested herein. Detection of CRX expression as well as genes activated by CRX (for example 
CONE ARRESTIN) indicates that CRX remains functional following the ZFN-mediated tagging 
with GFP.  
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Reporter lines that facilitate the detection of emerging photoreceptors are a useful 
tool for monitoring and improving hESC/hiPSC differentiation protocols towards retinal 
lineages and also enable the selection of specific cell types, analysis of their molecular and 
cell surface profile and engraftment capacity. Using plasmid and lentiviral based approaches, 
a few reporter hESC and hiPSC lines have been generated in order to monitor the 
emergence of retinal ganglion like cells [20] and photoreceptors [21]. Both of these 
approaches can suffer from random integration into the genome and subsequent silencing 
of reporter cassettes [5]. Insertion of promoter-reporter constructs into safe loci (for 
example, AAVS1) has also been suggested as a potential way of circumventing the silencing 
of the reporter cassettes; however this method still suffers from the limitations imposed by 
the selected promoter region being inserted into the cassette, which may not fully replicate 
the regulatory region of the endogenous gene. To bypass these issues, we have applied ZFN 
technology combined with the inherent repair of DNA DSBs by homologous recombination 
to generate a hESC line which harbours the GFP reporter as a 3’ terminal fusion of the 
endogenous CRX gene, a well described marker of post mitotic photoreceptor precursors.  
The reason for targeting 3’ of CRX was based on previous findings in the mouse system 
which indicated that the 5’UTR (up to 12 Kb) was not sufficient to direct high level reporter 
gene expression in photoreceptor cells compared to a mixture of 5’ and 3’ UTR regions in 
murine transgenic lines [15]. Generating a 3’ reporter fusion presents several advantages, 
such as maintenance of the full-length gene sequence with less likelihood of disruption of 
the coding sequence whilst maximising the similarity of reporter expression to that of the 
endogenous gene, however it also presents technical challenges related to the presence of 
AT-rich sequences commonly found at the 3’ UTR [22], which are notoriously difficult to 
clone (and hence to construct the integrating cassette) and are also less preferable for ZFN 
targeting when compared to GC-rich regions [23, 24]. This potential for lower integration 
efficiency did not pose a problem for our study as we were able to isolate 82 clones and 
further characterise three CRX-GFP targeted hESC clones (one homozygous and two 
heterozygous), which met the full assessment criteria for pluripotency, indicating that CRX 
targeting is compatible with the maintenance of pluripotency. Most importantly, no 
genomic abnormalities were observed after copy number analysis and sequencing of the 
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top 15 most likely cutting sites, suggesting that the CRX-GFP targeted clones generated in 
this study provide a bona fide tool for hESC retinal differentiation studies. 
Since CRX is not expressed at the pluripotent stem cell stage we subjected our 
targeted clones to our recently described 3D retinal differentiation protocol [12] and 
performed immunocytochemistry with antibodies against CRX and GFP during both early 
and late stages of differentiation. The anti-GFP antibody was employed for co-
immunocytochemistry with antibodies against cellular markers due to the observation of 
reduced GFP fluorescence following processing for immunocytochemistry and to obtain 
comparable levels of fluorescence intensity between both antibodies allowing optimal 
image clarity when performing the co-staining. With this method we were able to show 
perfect correlation between the expression and localisation of CRX and GFP, suggesting that 
the GFP reporter accurately mimics the expression of endogenous CRX during hESC 
differentiation. Importantly, we were also able to detect GFP expression without the need 
for immunocytochemistry indicating that GFP confers sufficient reporter activity to monitor 
the emergence of CRX expressing cells during hESC differentiation. The ability to detect CRX 
expression also indicated that expression of CRX had not been adversely hampered by ZFN-
mediated tagging with GFP. Furthermore, CRX protein has been shown to be required for 
the transactivation of its own gene expression and its maintenance [25]; henceforth, 
continued detection of CRX mRNA and protein expression throughout our differentiation 
time course further reinforces the notion that ZFN-mediated GFP tagging has not interfered 
with CRX function. 
Expression studies in human foetal retina have suggested that CRX is expressed in 
photoreceptors and in the inner nuclear layer [26] and mouse transgenic studies have also 
shown CRX expression in bipolar cells in addition to photoreceptors [15, 25]. To investigate 
the expression of CRX during hESC differentiation we performed immunocytochemistry with 
retinal precursor and retinal lineage markers. We further validated this analysis by 
performing quantitative RT-PCR of GFP positive and negative populations isolated by FACS. 
We found that the GFP positive population displayed increased expression of photoreceptor 
markers (CRX, RECOVERIN and CONE ARRESTIN) when compared to the GFP negative 
population or unsorted cells. In addition to transactivating its own expression, CRX protein 
has been shown to be important for activating and maintaining the expression of several 
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key photoreceptor genes [25, 27, 28, 29, 30]. For example, the CONE ARRESTIN gene 
harbours several CRX binding sites in its promoter region which are important for its 
activation [31, 32, 33], hence expression of CONE ARRESTIN in the CRX-GFP positive 
population indicates that the CRX protein remains functional and able to activate 
downstream targets after ZFN-mediated GFP tagging. 
It was interesting to observe that the expression of RHODOPSIN, a mature rod 
photoreceptor marker, was greater in the GFP negative subpopulation, suggesting confined 
expression of the GFP reporter to photoreceptor precursors emerging during 90 days of 
hESC differentiation. While we could detect expression of cone opsins in a punctate pattern 
that may be typical of an immature phenotype, we were unable to observe mature rod 
markers by immunocytochemistry, which indicates either a very low frequency of rod 
differentiation at day 90, or that the ontogenic stage of day 90 hESC-derived retinal tissue 
precedes the developmental peak of rod genesis, akin to the pattern of retinal cell 
emergence during human development. These data however should be interpreted with 
caution, as the expression of opsins in our study was low or of an immature nature. These 
findings are corroborated by a recent publication [19] and suggest that longer 
differentiation experiments are required to investigate CRX reporter expression in 
photoreceptors that display an advanced stage of morphological features and 
electrophysiological function. When compared to developmental retina at 18 weeks of 
gestation, higher CONE ARRESTIN expression was observed in the CRX-GFP positive 
population, perhaps indicating a more advanced stage of cone genesis in the CRX positive 
population isolated from hESC differentiation, though this needs to be further investigated 
using comparative analysis with retina obtained at additional developmental periods. 
Intriguingly NRL expression is observed in the foetal retina but is absent from the CRX-GFP 
positive population. This together with the expression of CONE ARRESTIN may mark these 
cells as cone-specific progenitors; however the heterogeneous nature of the hESC 
differentiation could equally yield populations of varying maturity with some cells beginning 
to acquire a cone photoreceptor fate whilst other cells are at an earlier post-mitotic 
photoreceptor progenitor phase and rod genesis is yet to occur. 
As outlined by previous studies in the mouse model [8] we also found that CRX 
expression was a marker of retinal progenitor cells that had exited the cell cycle, as assessed 
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by lack of Ki67 expression in the GFP positive subpopulation. We also found a small 
percentage of CRX positive cells that did not co-express RECOVERIN both in hESC-derived 
laminated retina and in human foetal retina. It is already known that in the developing 
retina progenitor cells undergo interkinetic nuclear migration, where the nucleus oscillates 
in an apical to basal fashion throughout the full thickness of the retinal neuroepithelium in 
synchrony with the cell cycle.  DNA duplication occurs towards the basal surface whilst 
mitosis occurs at the apical aspect. Some of the CRX-GFP positive cells lacking RECOVERIN 
expression were situated towards the apical surface, so it is possible that they move 
towards this rim to complete mitosis before acquiring RECOVERIN expression and 
committing to a photoreceptor fate. If this were the case, these cells should also express 
Ki67.  However our analysis indicated that all CRX positive cells lack Ki67 expression leaving 
open the question of what these cells may be.  Earlier studies in mouse transgenic models 
have shown that CRX expression can also be detected in bipolar cells [15]; however we did 
not observe any CRX cells to express PKCα, ruling out the subset of bipolar cells 
characterised by the expression of this marker. Clearly, further studies are required to 
investigate this CRX population more completely; however the GFP reporter described in 
this manuscript would also enable laser dissection capture of this subset of CRX positive 
cells and permit further analysis at the transcriptional level to help determine their identity. 
In conclusion we have successfully generated CRX-GFP reporter hESC lines, which 
can be used to study the molecular and cell surface profile of human photoreceptor 
precursors and enable their isolation for transplantation studies. We hope that these hESC 
lines will provide a universally useful tool with which to monitor and improve differentiation 
protocols, discover useful cell surface markers and develop clinically applicable strategies 
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Figure 1: ZFN mediated targeting of GFP to the 3’ UTR of CRX. A) Schematic diagram of 
endogenous CRX gene structure, targeting cassette, targeting strategy and sequencing data 
from sections of the insertion site, the endogenous CRX-exogenous eGFP border site and 3’ 
homology arm-endogenous CRX border, obtained from three analysed hESC clones; B) PCR 
of three hESC clones with primers spanning the integration site to assess whether the 
cassette had integrated at the correct site. Depending on size of band produced (upper 
band of 5067bp with integration, lower band of 2171bp without) and whether the clone has 
a heterozygous integration (by the presence of the upper and lower bands), or a 
homozygote integration (a single upper band), such as clone 1 in the first lane. Lanes 2 & 3 
show two clones with heterozygote integration, lanes 4-6 are genomic DNA from control 
untreated H9 hESCs and lane 7, a no template negative PCR control. This is a representative 
example of at least 3 repeats; C) qPCR mediated copy number analysis indicating presence 
of two copies of GFP (and hence targeting cassette) in CRX-GFP hESC clone 1 (c1) and its 
absence from wild type H9 hESC genomic DNA, data is presented as the mean ± SEM (n=3). 
 
Figure 2.  GFP reporter accurately mimics the expression of endogenous CRX during hESC 
differentiation. (A-L) Immunocytochemistry with antibodies raised against CRX and GFP 
showing correlation at day 30 (A-D), day 60 (E-H) and day 90 (I-L) of hESC differentiation.  M) 
Detection of GFP without antibody using confocal microscopy. Scale bars= 20 µm. 
 
Figure 3. CRX/GFP expression is found in photoreceptor precursors at day 60 of hESC 
differentiation. Immunocytochemistry with antibodies raised against GFP and Recoverin (A 
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and B), OPN1SW (C), OPN1MW/LW (D), Calbindin (E), HuC/D (F) and Ki-67 (G). Scale bars = 
20 µm (A, F), 5 µm (B) and 10 µm (C, D and E). 
 
Figure 4. CRX expression in photoreceptor precursors assessed by immunocytochemistry 
and qRT-PCR at day 90 of differentiation. Immunocytochemistry with antibodies raised 
against GFP and Recoverin (A), OPN1SW (B), OPN1MW/LW (C), PKCα (D), HuC/D (E) and Ki-
67 (F). Scale bars = 10 µm (E) and 20 µm (A, B, C, D and F); (G) Flow activated cell sorting of 
GFP positive (green) and GFP negative (red) populations; (H) and (I) qRT-PCR analysis of 
unsorted, flow activated cell sorted GFP positive (Sorted GFP+) and GFP negative (Sorted 
GFP-) populations and foetal retina at 18 weeks of gestation (18w Foetal Retina), indicating 
CRX, RECOVERIN (RCVRN) and CONE ARRESTIN (C-ARR) expression in the GFP positive 
population. Expression of short, medium and long wave opsins (OPN1SW, OPN1MW & 
OPN1LW) and rhodopsin (RHO) are also shown. Data is presented as the mean ± SEM (n=3). 
Significant differences found are marked with an asterisk (*).  
 
 
Suppl. Figure 1: Surveyor mutation detection assay performed in K562 cells and hESCs to 
indicate ZFN cutting efficiency. As shown, a higher ZFN cutting efficiency is observed in 
K562 cells than hESCs (which may be related to lower non homologous end joining repair 
pathway efficiency observed in hESCs). Upon cleavage of the target site by the ZFN pair 
inaccurate repair by the non-homologous end joining pathway can occur resulting in 
insertion or deletion of nucleotides. Following PCR of the target region and cooling of the 
PCR products duplexes form. In the presence of NHEJ-repaired and wild-type 
heteroduplexes and the SURVEYOR/CEL-I enzyme cleavage products are produced. The 221 
and 150 bp bands represent the cleavage of PCR products generated across the CRX 3’ UTR 
target cut site in the presence of an insertion or deletion, in the absence of an insertion or 
deletion a wild-type PCR product of 371 bp is observed. (A) K562 cells; lane 1, PCR of wild-
type genomic DNA (No), lanes 2 & 3, PCR of genomic DNA following ZFN pair transfection 
(ZFN); (B) hESC H9 cells; lane 1, PCR of wild-type genomic DNA (No), lane 2, PCR of genomic 
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DNA following a mock nucleofection without ZFNs (Mock) & lane 3, PCR of genomic DNA 
following ZFN pair nucleofection (ZFN). 
 
Suppl. Figure 2: The sequence of CRX-GFP targeting construct. The sequences of CRX 5’ and 
3’ homology arms, eGFP reporter and puromycin resistance cassette are shown as 
highlighted in the key. 
 
Suppl. Figure 3: CRX-GFP targeted hESC clones maintain a normal karyotype and exhibit 
pluripotency. (A) Normal karyotype (46 XX) observed in CRX-GFP hESC clone 1; (B) 
Pluripotent marker staining (OCT4 and SSEA4) in CRX-GFP hESC clone 1; (C) Three germ layer 
differentiation capacity assessed by the presence of endodermal cells (marked by AFP 
staining), ectodermal cells (marked by TUJ1 staining) and mesodermal cells (marked by SMA) 
in embryoid bodies derived from differentiation of CRX-GFP hESC clone 1; (D) Histological 
analysis of xenograft tumours formed from engrafted CRX-GFP hESC clone 3.  The teratomae 
produced contained tissues representative of endoderm (a), mesoderm (b) and ectoderm 
(c).  Example tissues included: (a) structure of primitive intestine showing epithelium (ep), 
villous (vi), submucosa (sb), and smooth muscle (sm); (b) cartilaginous masses (ct); (c) 
neuro-epithelium (ne).  Counterstain: Haematoxylin and Eosin.  Scale bars: (a-c) 150 microns. 
 
Suppl. Figure 4: CRX is not expressed in early stages of eye cup formation. 
Immunocytochemistry with antibodies raised against GFP, RAX (A) and PAX6 (B) (both 
markers of eyefield development) at day 60 of differentiation. Scale bars= 20 µM. 
 
Suppl. Figure 5: CRX and RECOVERIN expression during early human fetal development at 
16 (A) and 18 weeks of gestation (B-D). Double positive CRX and RECOVERIN expressing 
cells are located in the developing outer nuclear layer. In addition CRX+RECOVERIN- cells are 
found in the neuroblastic layer. Scale bars= 100 µM (A) and 50 µM (B-D). 
Page 23 of 44
































































Suppl. Table 1: ZFN pair target sites, PCR primers, sequencing primers. 
 
Suppl. Table 2: ZFN pair off-target analysis. Off-target site sequences, primer details and 
sequencing. 
 
Suppl. Table 3: Antibodies used during this study. 
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ZFN mediated targeting of GFP to the 3’ UTR of CRX. A) Schematic diagram of endogenous CRX gene 
structure, targeting cassette, targeting strategy and sequencing data from sections of the insertion site, the 
endogenous CRX-exogenous eGFP border site and 3’ homology arm-endogenous CRX border, obtained from 
three analysed hESC clones; B) PCR of three hESC clones with primers spanning the integration site to 
assess whether the cassette had integrated at the correct site. Depending on size of band produced (upper 
band of 5067bp with integration, lower band of 2171bp without) and whether the clone has a heterozygous 
integration (by the presence of the upper and lower bands), or a homozygote integration (a single upper 
band), such as clone 1 in the first lane. Lanes 2 & 3 show two clones with heterozygote integration, lanes 4-
6 are genomic DNA from control untreated H9 hESCs and lane 7, a no template negative PCR control. This is 
a representative example of at least 3 repeats; C) qPCR mediated copy number analysis indicating presence 
of two copies of GFP (and hence targeting cassette) in CRX-GFP hESC clone 1 (c1) and its absence from wild 
type H9 hESC genomic DNA, data is presented as the mean ± SEM (n=3).  
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GFP reporter accurately mimics the expression of endogenous CRX during hESC differentiation. (A-L) 
Immunocytochemistry with antibodies raised against CRX and GFP showing correlation at day 30 (A-D), day 
60 (E-H) and day 90 (I-L) of hESC differentiation.  M) Detection of GFP without antibody using confocal 
microscopy. Scale bars= 20 µm.  
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CRX/GFP expression is found in photoreceptor precursors at day 60 of hESC differentiation. 
Immunocytochemistry with antibodies raised against GFP and Recoverin (A and B), OPN1SW (C), 
OPN1MW/LW (D), Calbindin (E), HuC/D (F) and Ki-67 (G). Scale bars = 20 µm (A, F), 5 µm (B) and 10 µm 
(C, D and E).  
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CRX expression in photoreceptor precursors assessed by immunocytochemistry and qRT-PCR at day 90 of 
differentiation. Immunocytochemistry with antibodies raised against GFP and Recoverin (A), OPN1SW (B), 
OPN1MW/LW (C), PKCα (D), HuC/D (E) and Ki-67 (F). Scale bars = 10 µm (E) and 20 µm (A, B, C, D and 
F); (G) Flow activated cell sorting of GFP positive (green) and GFP negative (red) populations; (H) and (I) 
qRT-PCR analysis of unsorted, flow activated cell sorted GFP positive (Sorted GFP+) and GFP negative 
(Sorted GFP-) populations and foetal retina at 18 weeks of gestation (18w Foetal Retina), indicating CRX, 
RECOVERIN (RCVRN) and CONE ARRESTIN (C-ARR) expression in the GFP positive population. Expression of 
short, medium and long wave opsins (OPN1SW, OPN1MW & OPN1LW) and rhodopsin (RHO) are also shown. 
Data is presented as the mean ± SEM (n=3). Significant differences found are marked with an asterisk (*).  
209x297mm (300 x 300 DPI)  
 
 
Page 29 of 44


































































Surveyor mutation detection assay performed in K562 cells and hESCs to indicate ZFN cutting efficiency. As 
shown, a higher ZFN cutting efficiency is observed in K562 cells than hESCs (which may be related to lower 
non homologous end joining repair pathway efficiency observed in hESCs). Upon cleavage of the target site 
by the ZFN pair inaccurate repair by the non-homologous end joining pathway can occur resulting in 
insertion or deletion of nucleotides. Following PCR of the target region and cooling of the PCR products 
duplexes form. In the presence of NHEJ-repaired and wild-type heteroduplexes and the SURVEYOR/CEL-I 
enzyme cleavage products are produced. The 221 and 150 bp bands represent the cleavage of PCR products 
generated across the CRX 3’ UTR target cut site in the presence of an insertion or deletion, in the absence of 
an insertion or deletion a wild-type PCR product of 371 bp is observed. (A) K562 cells; lane 1, PCR of wild-
type genomic DNA (No), lanes 2 & 3, PCR of genomic DNA following ZFN pair transfection (ZFN); (B) hESC 
H9 cells; lane 1, PCR of wild-type genomic DNA (No), lane 2, PCR of genomic DNA following a mock 
nucleofection without ZFNs (Mock) & lane 3, PCR of genomic DNA following ZFN pair nucleofection (ZFN).  
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CRX-GFP targeted hESC clones maintain a normal karyotype and exhibit pluripotency. (A) Normal karyotype 
(46 XX) observed in CRX-GFP hESC clone 1; (B) Pluripotent marker staining (OCT4 and SSEA4) in CRX-GFP 
hESC clone 1; (C) Three germ layer differentiation capacity assessed by the presence of endodermal cells 
(marked by AFP staining), ectodermal cells (marked by TUJ1 staining) and mesodermal cells (marked by 
SMA) in embryoid bodies derived from differentiation of CRX-GFP hESC clone 1; (D) Histological analysis of 
xenograft tumours formed from engrafted CRX-GFP hESC clone 3.  The teratomae produced contained 
tissues representative of endoderm (a), mesoderm (b) and ectoderm (c).  Example tissues included: (a) 
structure of primitive intestine showing epithelium (ep), villous (vi), submucosa (sb), and smooth muscle 
(sm); (b) cartilaginous masses (ct); (c) neuro-epithelium (ne).  Counterstain: Haematoxylin and 
Eosin.  Scale bars: (a-c) 150 microns.  
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CRX is not expressed in early stages of eye cup formation. Immunocytochemistry with antibodies raised 
against GFP, RAX (A) and PAX6 (B) (both markers of eyefield development) at day 60 of differentiation. 
Scale bars= 20 µM.  
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CRX and RECOVERIN expression during early human fetal development at 16 (A) and 18 weeks of gestation 
(B-D). Double positive CRX and RECOVERIN expressing cells are located in the developing outer nuclear 
layer. In addition CRX+RECOVERIN- cells are found in the neuroblastic layer. Scale bars= 100 µM (A) and 
50 µM (B-D).  
209x297mm (300 x 300 DPI)  
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GFP Sequencing Primer TTACGTCGCCGTCCAGCTC
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Supplementary Table 2: Off-target site analysis performed with PROGNOS and sequencing of the resultant PCR products from H9 CRX-GFP clone 1 genomic DNA. Ranking number 1 is the correct ZFN pair targeting sites.
PROGNOS (Version 1) Ranked Output:
Ranking Nuclease Orientation Spacer Length Mismatches Left Half Site Spacer
1 L-5-R 5 0_0 CTGAATCTGCTTCCCTGC agttt
2 L-6-L 6 4_4 CTacgcCTGCTTCCCTGC gatcca
3 R-5-L 5 4_3 GCCATgagtGGATCT gaagc
4 R-6-R 6 5_1 cCCATCCCGGGATCT ccctgt
5 R-6-L 6 5_3 aCCATCCCaGGcTCT cccgca
6 R-6-L 6 5_5 GCCtTCCCtcccTCT gctgct
7 L-6-L 6 5_5 CTGgAcCTGaTaCCCaGC aggtgt
8 L-5-R 5 5_5 accAAgCTGCTgCCCTGC acagg
9 L-5-R 5 4_4 CTGgcTCcaCTTCCCTGC ttttt
10 R-6-R 6 5_3 GagATCagaGGATCT ccaaac
11 L-5-L 5 5_5 gccAAaCTGCTTCCaTGC aggag
12 R-5-R 5 4_4 cCCcTCCCtGGATCa tgtct
13 L-5-R 5 5_3 CTGcAgCTGCTTCCCaGC acaaa
14 R-6-R 6 5_2 GCCcTCCtGtGAaCc cagcac
15 R-6-L 6 5_4 GCCATCtgGGttTCT gccagg
16 R-6-R 6 5_4 cCCAaCCCtaGgTCT ccacaa
Collin et al. 2015
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Supplementary Table 2: Off-target site analysis performed with PROGNOS and sequencing of the resultant PCR products from H9 CRX-GFP clone 1 genomic DNA. Ranking number 1 is the correct ZFN pair targeting sites.
Right Half Site Chromosome Name Chromosome Location Genomic Region
AGATCCCGGGATGGC chr19 48343274 Exon
GCAGtGAAGCAGgTgtAG chr8 74689849 Intergenic
GCAGGGAgGCAGAagCAG chr7 26661904 Intergenic
AccTCCtGGcAgGGC chr19 6590640 Intron
GgAGGGAAGCAGcTcCct chr6 160308315 Intergenic
GCAGGGAAGCtGAccaAa chrX 48460428 Intron
GCAGGGAAaggtATgCAG chr19 31560623 Intergenic
tGgTCCCGGcgaGGC chr1 10748837 Intron
AaATCCtGGGATtGa chr6 168582079 Intergenic
AGATCCaGaGAaGGC chr1 40954614 Intron
GgAGGGAAGCctgcTCAG chr17 47975818 Intergenic
AGAagtCaGGATGGC chr11 5405799 Intron
cGgTCCtGcGAgGGC chr18 76007140 Intergenic
AGATCCtGGGcTGGC chr16 86016582 Intergenic
GCAGGGAAaCcaAagCAG chr2 62597922 Intergenic
AGActtCGGGATGcC chr17_gl000206_random 37198 Intergenic
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Supplementary Table 2: Off-target site analysis performed with PROGNOS and sequencing of the resultant PCR products from H9 CRX-GFP clone 1 genomic DNA. Ranking number 1 is the correct ZFN pair targeting sites.
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ScholarOne Support: (434) 964-4100
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